These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32142717)

  • 1. Molecular profiling in Parkinsonian syndromes: CSF biomarkers.
    Paolini Paoletti F; Gaetani L; Parnetti L
    Clin Chim Acta; 2020 Jul; 506():55-66. PubMed ID: 32142717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions.
    Magdalinou N; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1065-75. PubMed ID: 24691581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
    Jabbari E; Woodside J; Guo T; Magdalinou NK; Chelban V; Athauda D; Lees AJ; Foltynie T; Houlden H; Church A; Hu MT; Rowe JB; Zetterberg H; Morris HR
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):768-773. PubMed ID: 30867224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls.
    Marques TM; van Rumund A; Bruinsma IB; Wessels HJCT; Gloerich J; Esselink RAJ; Bloem BR; Kuiperij HB; Verbeek MM
    Mol Neurobiol; 2019 Jul; 56(7):5067-5074. PubMed ID: 30465235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
    Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M
    Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.
    Ge F; Ding J; Liu Y; Lin H; Chang T
    Neurosci Lett; 2018 Oct; 685():35-41. PubMed ID: 30036569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DJ-1 concentration in cerebrospinal fluid does not differentiate among Parkinsonian syndromes.
    Salvesen L; Bech S; Lokkegaard A; Hjermind LE; Nielsen JE; Pakkenberg B; Tanassi JT; Heegaard NH; Winge K
    Parkinsonism Relat Disord; 2012 Aug; 18(7):899-901. PubMed ID: 22503539
    [No Abstract]   [Full Text] [Related]  

  • 9. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K
    Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes.
    Holmberg B; Johnels B; Ingvarsson P; Eriksson B; Rosengren L
    Parkinsonism Relat Disord; 2001 Sep; 8(1):23-31. PubMed ID: 11472877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
    Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
    Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "De-novo" consultation: Evaluation of an outpatient's clinic dedicated to early diagnosis of parkinsonian syndromes.
    Ruggeri J; Mariani LL; Aix S; Bonnet AM; Cormier F; Corvol JC; Dodet P; Grabli D; Hartmann A; Hubsch C; Lacomblez L; Roze E; Welter ML; Worbe Y; Vidailhet M; Degos B
    Rev Neurol (Paris); 2017; 173(1-2):55-61. PubMed ID: 28159316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.
    Constantinescu R; Andreasson U; Li S; Podust VN; Mattsson N; Anckarsäter R; Anckarsäter H; Rosengren L; Holmberg B; Blennow K; Wikkelsö C; Rüetschi U; Zetterberg H
    Parkinsonism Relat Disord; 2010 Sep; 16(8):545-9. PubMed ID: 20620095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes.
    Jurjević I; Miyajima M; Ogino I; Akiba C; Nakajima M; Kondo A; Kikkawa M; Kanai M; Hattori N; Arai H
    J Alzheimers Dis; 2017; 56(1):317-325. PubMed ID: 27911315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.
    Farotti L; Paciotti S; Tasegian A; Eusebi P; Parnetti L
    Expert Rev Mol Diagn; 2017 Aug; 17(8):771-780. PubMed ID: 28604235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein real-time quaking-induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism.
    van Rumund A; Green AJE; Fairfoul G; Esselink RAJ; Bloem BR; Verbeek MM
    Ann Neurol; 2019 May; 85(5):777-781. PubMed ID: 30801759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonian syndromes and differential diagnosis.
    Kashmere J; Camicioli R; Martin W
    Curr Opin Neurol; 2002 Aug; 15(4):461-6. PubMed ID: 12151844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers.
    Paolini Paoletti F; Gaetani L; Parnetti L
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32092971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Approach to Atypical Parkinsonian Syndromes.
    McFarland NR
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1117-42. PubMed ID: 27495201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.